Federal Register / Vol. 74, No. 96 / Wednesday, May 20, 2009 / Notices 23733 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Jessica Sapienza, 

Executive Secretary, National Children’s 

Study, Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, NIH, 6100 Executive Blvd., 

Room 3A01, Bethesda, MD 20892, (703) 902– 

1339, ncs@circlesolutions.com. 

This meeting is being published less than 

15 days prior to the meeting due to timing 

limitations imposed by administrative 

matters. 

Name of Committee: National Children’s 

Study Advisory Committee; Scientific 

Review Subcommittee. 

Date: May 26, 2009. 

Time: 2:30 p.m. to 4 p.m. 

Agenda: The agenda will include a 

discussion on childhood obesity and the 

Committee’s role in scientific review. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Jessica Sapienza, 

Executive Secretary, National Children’s 

Study, Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, NIH, 6100 Executive Blvd., 

Room 3A01, Bethesda, MD 20892, (703) 902– 

1339, ncs@circlesolutions.com. 

This meeting is being published less than 

15 days prior to the meeting due to timing 

limitations imposed by administrative 

matters. 

Name of Committee: National Children’s 

Study Advisory Committee; Ethics 

Subcommittee. 

Date: May 26, 2009. 

Time: 2:30 p.m. to 4 p.m. 

Agenda: The agenda will include a 

discussion on current ethical issues in the 

National Children’s Study. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Jessica Sapienza, 

Executive Secretary, National Children’s 

Study, Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, NIH, 6100 Executive Blvd., 

Room 3A01, Bethesda, MD 20892, (703) 902– 

1339, ncs@circlesolutions.com. 

This meeting is being published less than 

15 days prior to the meeting due to timing 

limitations imposed by administrative 

matters. 

Name of Committee: National Children’s 

Study Advisory Committee; Community 

Outreach and Engagement Subcommittee. 

Date: May 26, 2009. 

Time: 2:30 p.m. to 4 p.m. 

Agenda: The agenda will include an 

update on community engagement in the 

National Children’s Study. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Jessica Sapienza, 

Executive Secretary, National Children’s 

Study, Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, NIH, 6100 Executive Blvd., 

Room 3A01, Bethesda, MD 20892, (703) 902– 

1339, ncs@circlesolutions.com. 

This meeting is being published less than 

15 days prior to the meeting due to timing 

limitations imposed by administrative 

matters. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: May 12, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–11577 Filed 5–19–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Musculoskeletal, Oral 

and Skin Sciences, Integrated Review Group, 

Skeletal Biology Structure and Regeneration 

Study Section. 

Date: June 1–2, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

Bethesda, MD 20852. 

Contact Person: John P. Holden, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4211, 

MSC 7814, Bethesda, MD 20892. (301) 496– 

8551. holdenjo@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Epidemiology and 

Population Studies, Integrated Review 

Group, Epidemiology of Cancer Study 

Section. 

Date: June 2–3, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Alexandria Old Town, 1767 

King Street, Alexandria, VA 22314. 

Contact Person: Denise Wiesch, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3150, 

MSC 7770, Bethesda, MD 20892. (301) 435– 

0684. wieschd@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Tumor 

Environment–ARRA–CR. 

Date: June 2, 2009. 

Time: 12 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Mayflower Park Hotel, 405 Olive 

Way, Seattle, WA 98101. 

Contact Person: Eun Ah Cho, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6202, 

MSC 7804, Bethesda, MD 20892. (301) 451– 

4467. choe@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Surgical Sciences, 

Biomedical Imaging and Bioengineering 

Integrated Review Group Surgery, 

Anesthesiology and Trauma Study Section. 

Date: June 4–5, 2009. 

Time: 8 a.m. to 11 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Allerton Hotel Chicago, 701 

North Michigan Avenue, Chicago, IL 60611. 

Contact Person: Weihua Luo, MD, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5114, 

MSC 7854, Bethesda, MD 20892. (301) 435– 

1170. luow@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, ZRG1 IFCN– 

H (95) S Revisions: Neurotoxicology and 

Alcohol. 

Date: June 4–5, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Four Points Sheraton, 1201 K Street, 

NW., Washington, DC 20005. 

Contact Person: Brian Hoshaw, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5181, 

MSC 7844, Bethesda, MD 20892. (301) 435– 

1033. hoshawb@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

23734 Federal Register / Vol. 74, No. 96 / Wednesday, May 20, 2009 / Notices 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Supplements to Macromolecular Structure 

and Function A. 

Date: June 4, 2009. 

Time: 2 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: George Washington University Inn, 

824 New Hampshire Avenue, NW., 

Washington, DC 20037. 

Contact Person: David R. Jollie, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4150, 

MSC 7806, Bethesda, MD 20892. (301) 435– 

1722. jollieda@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Healthcare Delivery 

and Methodologies, Biostatistical Methods 

and Research Design Study Section. 

Date: June 5, 2009. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: George Washington University Inn, 

824 New Hampshire Avenue, NW., 

Washington, DC 20037. 

Contact Person: Denise Wiesch, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3150, 

MSC 7770, Bethesda, MD 20892. (301) 435– 

0684. wieschd@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, NOMD 

ARRA Competing Revisions. 

Date: June 5, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington DC/Silver 

Spring, 8727 Colesville Road, Silver Spring, 

MD 20910. 

Contact Person: Carol Hamelink, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5040H, 

MSC 7850, Bethesda, MD 20892. (301) 451– 

1328. hamelinc@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, NTRC 

Competitive Revision Review. 

Date: June 5, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Westin St. Francis Hotel, 335 

Powell Street, San Francisco, CA 94102. 

Contact Person: Peter B. Guthrie, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4142, 

MSC 7850, Bethesda, MD 20892. (301) 435– 

1239. guthriep@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Bioengineering 

Sciences & Technologies, Integrated Review 

Group Modeling and Analysis of Biological 

Systems Study Section. 

Date: June 5, 2009. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Churchill Hotel, 1914 Connecticut 

Avenue, NW., Washington, DC 20009. 

Contact Person: Raymond Jacobson, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, MSC 7849, 

Bethesda, MD 20892. (301) 435–0483. 

jacobsonrh@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Social 

Psychology: ARRA Revised Applications. 

Date: June 5, 2009. 

Time: 8 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Mayflower Park Hotel, 405 Olive 

Way, Seattle, WA 98101. 

Contact Person: Michael Micklin, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3136, 

MSC 7759, Bethesda, MD 20892. (301) 435– 

1258. micklinm@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Neurotechnology 2. 

Date: June 5, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Melrose Hotel, 2430 Pennsylvania 

Avenue, NW., Washington, DC 20037. 

Contact Person: Robert C. Elliott, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3130, 

MSC 7850, Bethesda, MD 20892. (301) 435– 

3009. elliotro@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, NAME 

Revision Applications. 

Date: June 5, 2009. 

Time: 8:30 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Palomar, 2121 P Street, NW., 

Washington, DC 20037. 

Contact Person: Heidi B. Friedman, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1012A, 

MSC 7770, Bethesda, MD 20892. (301) 435– 

0906. hfriedman@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, CP: Review 

of Competing Revisions. 

Date: June 5, 2009. 

Time: 9 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Renaissance M Street Hotel, 1443 

New Hampshire Avenue, NW., Washington, 

DC 20037. 

Contact Person: Cheri Wiggs, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3180, 

MSC 7848, Bethesda, MD 20892. (301) 435– 

1261. wiggsc@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, MGA 

Revisions. 

Date: June 5, 2009. 

Time: 10 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Renaissance M Street Hotel, 1143 

New Hampshire Avenue, NW., Washington, 

DC 20037. 

Contact Person: Michael M. Sveda, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2204, 

MSC 7890, Bethesda, MD 20892. (301) 435– 

3565. svedam@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, SYN 

Competitive Revisions. 

Date: June 5, 2009. 

Time: 10 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Alexandria Old Town, 1767 

King Street, Alexandria, VA 22314. 

Contact Person: Jonathan K. Ivins, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4040A, 

MSC 7806, Bethesda, MD 20892. (301) 594– 

1245. ivinsj@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, MABS SRO 

Conflict Panel. 

Date: June 5, 2009. 

Time: 1 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Churchill Hotel, 1914 Connecticut 

Avenue, NW., Washington, DC 20009. 

Contact Person: Amy L. Rubinstein, PhD, 

Scientific Review Officer, Center for 

Federal Register / Vol. 74, No. 96 / Wednesday, May 20, 2009 / Notices 23735 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Rm 5152, MSC 

7844, Bethesda, MD 20892. (301) 435–1159. 

rubinsteinal@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, NCF 

Competitive Revisions. 

Date: June 5, 2009. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street, NW., Washington, DC 20037. 

Contact Person: Lawrence Baizer, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4152, 

MSC 7850, Bethesda, MD 20892. (301) 435– 

1257. baizer@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, BPNS 

Competitive Revisions. 

Date: June 5, 2009. 

Time: 2 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Westin St. Francis Hotel, 335 

Powell Street, San Francisco, CA 94102. 

Contact Person: Geoffrey G. Schofield, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4040–A, 

MSC 7850, Bethesda, MD 20892. (301) 435– 

1235. geoffreys@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Biomedical 

Informatics. 

Date: June 5, 2009. 

Time: 2 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Bill Bunnag, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3156, 

MSC 7770, Bethesda, MD 20892. (301) 435– 

1177. bunnagb@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, APDA: 

Review of Competing Revisions. 

Date: June 5, 2009. 

Time: 3 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Allerton Hotel Chicago, 701 

North Michigan Avenue, Chicago, IL 60611. 

Contact Person: Estina E. Thompson, PhD, 

MPH, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3178, 

MSC 7848, Bethesda, MD 20892. (301) 496– 

5749. thompsone@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Collaborative Applications in Adult 

Psychopathology and Disorders of Aging. 

Date: June 5, 2009. 

Time: 12 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Allerton Hotel Chicago, 701 

North Michigan Avenue, Chicago, IL 60611. 

Contact Person: Estina E. Thompson, PhD, 

MPH, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3178, 

MSC 7848, Bethesda, MD 20892. (301) 496– 

5749. thompsone@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, CMBG 

ARRA Competing Revisions. 

Date: June 5, 2009. 

Time: 12 p.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Toby Behar, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4136, 

MSC 7850, Bethesda, MD 20892. (301) 435– 

4433. behart@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Psychosocial Risk Prevention: ARRA 

Renewal Applications. 

Date: June 5, 2009. 

Time: 12 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Avenue Hotel Chicago, 160 Huron 

Street, Chicago, IL 60611. 

Contact Person: Anna L. Riley, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3114, 

MSC 7759, Bethesda, MD 20892. (301) 435– 

2889. rileyann@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: May 11, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–11580 Filed 5–19–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Prospective Grant of Exclusive 

License: The Development of 

Thalidomide Analogs for the Treatment 

of Cancer 

AGENCY: National Institutes of Health, 

Public Health Service, HHS. 

ACTION: Notice. 

SUMMARY: This is notice, in accordance 

with 35 U.S.C. 209(c)(1) and 37 CFR 

part 404.7(a)(1)(i), that the National 

Institutes of Health, Department of 

Health and Human Services, is 

contemplating the grant of an exclusive 

patent license to practice the inventions 

embodied in US Patent Application 60/ 

792,098 entitled ‘‘Tetrahalogenated 

Compounds Useful as Inhibitors’’ [HHS 

Ref. E–080–2006/0–US–01], PCT 

Application PCT/US2007/008849 

entitled ‘‘Tetrahalogenated Compounds 

Useful as Inhibitors’’ [HHS Ref. E–080– 

2006/0–PCT–02], Australian Patent 

Application 2007238785 entitled ‘‘A 

New Series Of Thalidomide Analogs 

That Have Potent Anti-angiogenic 

Properties’’ [HHS Ref. E–080–2006/0– 

AU–03], Canadian Patent Application 

2,648,216 entitled ‘‘A New Series Of 

Thalidomide Analogs That Have Potent 

Anti-angiogenic Properties’’ [HHS Ref. 

E–080–2006/0–CA–04], European Patent 

Application 07755201.6 entitled ‘‘A 

New Series Of Thalidomide Analogs 

That Have Potent Anti-angiogenic 

Properties’’ [HHS Ref. E–080–2006/0– 

EP–05], US Patent Application 12/ 

287,597 entitled ‘‘A New Series Of 

Thalidomide Analogs That Have Potent 

Anti-angiogenic Properties’’ [HHS Ref. 

E–080–2006/0–US–06], and all 

continuing patents, patent applications, 

and foreign counterparts thereto, to 

CuriRx, Inc., which has offices in 

Andover, Massachusetts. The patent 

rights in these inventions have been 

assigned to and/or exclusively licensed 

to the Government of the United States 

of America. 

The prospective exclusive license 

territory may be worldwide, and the 

field of use may be limited to: 

The use of Gu998 (Compound 19e), Gu973 

(Compound 19f), Gu1029 (Compound 20d) or 

Gu992 (Compound 20g) as cancer 

therapeutics.